Visit this section

Healthcare professionals

Public
wooden-background


ECNP 2021 HIGHLIGHTS



Follow our congress highlights by subscribing to our newsletter

Don’t have an account? Register for free with DocCheck

THE EVOLVING LANDSCAPE OF DIGITAL TOOLS TO ASSESS PATIENTS WITH SCHIZOPHRENIA

THE EVOLVING LANDSCAPE OF DIGITAL TOOLS TO ASSESS PATIENTS WITH SCHIZOPHRENIA

During his presentation, Martien Kas, Professor of Behavioral Neuroscience of the Groningen Institute for Evolutionary Life Sciences at the University of Groningen in the Netherlands, discussed how digital tools such as smartphones, smartwatches, and other wearable healthcare devices are capable of not only measuring patients’ physical movements, but also capturing data on their mental health and general well-being.

COGNITIVE REMEDIATION IN SCHIZOPHRENIA NEW EVIDENCE AND FUTURE PERSPECTIVES IN THE DIGITAL ERA

COGNITIVE REMEDIATION IN SCHIZOPHRENIA NEW EVIDENCE AND FUTURE PERSPECTIVES IN THE DIGITAL ERA

The schizophrenia polypharmacy quiz – everything you need to know about combining antipsychotics’ was an interactive session at the 34th ECNP Congress. Professor Stephan Hjorth and his co-speaker Dr. Karolina Leopold addressed the efficacy and safety concerns of different antipsychotic combinations from a pharmacological and clinical point of view

BRIDGING ADHERENCE TO LONG-TERM FUNCTIONING IN SCHIZOPHRENIA

BRIDGING ADHERENCE TO LONG-TERM FUNCTIONING IN SCHIZOPHRENIA

During the ‘From symptom control to long-term functioning – bridging treatment adherence to functional recovery in schizophrenia’ symposium, four expert speakers looked at the importance of linking acute and long-term treatment objectives in early schizophrenia. In particular, the case for giving a medication that patients will be certain to take was emphasized, with speakers making the case for using long-acting injectable (LAI) antipsychotic drugs earlier in the course of the illness.

THINKING CLEARLY WITH SCHIZOPHRENIA – IS COGNITIVE IMPAIRMENT THE OBSTACLE HOLDING YOUR PATIENT BACK?

THINKING CLEARLY WITH SCHIZOPHRENIA – IS COGNITIVE IMPAIRMENT THE OBSTACLE HOLDING YOUR PATIENT BACK?

Professors Peter Falkai, Dr. Berlet, Dr. Nagore Penades, Professor and Philip D. Harvey outlined the reality of living with cognitive impairment associated with schizophrenia and the impact this has on both the patient and their loved ones.

THE COVID-19 PANDEMIC: IMPLICATIONS FOR PHYSICAL AND MENTAL HEALTH OF PEOPLE LIVING WITH SCHIZOPHRENIA

THE COVID-19 PANDEMIC: IMPLICATIONS FOR PHYSICAL AND MENTAL HEALTH OF PEOPLE LIVING WITH SCHIZOPHRENIA

The symposium provided an update on the impact of COVID-19 on health status, treatment management, and access to care for people with schizophrenia.

Showing 0 result(s).
Please log in to see 0 more result(s).